New

DIASYST Inc.

The AI engine Fit Assessment

Beta

The company will be attending ViVE 2025 Event

Blurb

Diasyst delivers solutions to simplify diabetes, other chronic disease management based on decades of clinical research & proven approaches.

HQ Location

Atlanta (United States)

Founded

2015

Employees

11 - 50

Total funding raised

$200.00K

Last Funding Event

Grant, $50.00K, January 9, 2019

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M

Diasyst launches the first Medication Intelligence solution for chronic disease management, enabling healthcare providers to make timely, quick, safe, and effective treatment decisions. Diasyst collects, computerizes, and maintains an ever-expanding knowledge base of thousands of pages of clinical guidelines, drug labels, research studies, and best practices, backed by decades of research at Emory University and the VA. Diasyst delivers treatment recommendations to decision-makers using our proprietary AI, saving time, increasing revenue, and optimizing patient outcomes.